Edit |   |
---|---|
Antigenic Specificity | IL12B, Human (Briakinumab biosimilar) |
Clone | Briakinumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 lambda |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | FCM, IP, ELISA, Neut, FuncS |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human IL12B Recombinant Antibody (Briakinumab). Briakinumab (ABT-874) is a human monoclonal antibody being developed by Abbott Laboratories for the treatment of rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis. As of 2011 drug development for psoriasis has been discontinued in the U.S. and Europe. |
Immunogen | n/a |
Other Names | Anti-IL12B Recombinant Antibody, Research Grade Briakinumab, Anti-Human IL12B Recombinant Antibody(Briakinumab), ABT-874, Antibody Drug Analogues, Monoclonal Antibody, YR1099, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 339308-60-0 |
Catalog # | YR1099 |
Price | please inquire |
Order / More Info | IL12B, Human (Briakinumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |